Feeding pure docosahexaenoate or arachidonate decreases plasma triacylglycerol secretion in rats.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 33 citations in OpenAlex.

1. Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.Nutrition & metabolism · 2005
   Article
2. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.Lipids · 1996
   Article
3. Evidence that dietary arachidonic acid increases circulating triglycerides.Lipids · 1995
   Article
4. Lipid peroxidation and antioxidant status is affected by different vitamin E levels when feeding fish oil.Lipids · 1994
   Article
5. Effect of 4,7,10,13,16,19-docosahexaenoic acid on triglyceride accumulation and secretion in rat hepatocytes in culture.Lipids · 1991
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors at 3 institutions in 2 countries.

Funding

Abstract

Indexed as